Zymeworks (ZYME) Invested Capital (2021 - 2025)
Zymeworks' Invested Capital history spans 5 years, with the latest figure at $268.5 million for Q4 2025.
- On a quarterly basis, Invested Capital fell 20.74% to $268.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $268.5 million, a 20.74% decrease, with the full-year FY2025 number at $268.5 million, down 20.74% from a year prior.
- Invested Capital hit $268.5 million in Q4 2025 for Zymeworks, down from $320.1 million in the prior quarter.
- Over the last five years, Invested Capital for ZYME hit a ceiling of $493.0 million in Q4 2022 and a floor of $179.8 million in Q3 2022.
- Historically, Invested Capital has averaged $350.8 million across 5 years, with a median of $336.6 million in 2024.
- Biggest five-year swings in Invested Capital: tumbled 35.55% in 2022 and later skyrocketed 136.06% in 2023.
- Tracing ZYME's Invested Capital over 5 years: stood at $249.1 million in 2021, then surged by 97.9% to $493.0 million in 2022, then fell by 5.71% to $464.8 million in 2023, then dropped by 27.12% to $338.8 million in 2024, then fell by 20.74% to $268.5 million in 2025.
- Business Quant data shows Invested Capital for ZYME at $268.5 million in Q4 2025, $320.1 million in Q3 2025, and $334.5 million in Q2 2025.